Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04155333 · ClinicalTrials.gov registry record · NA
Effects of Non-Invasive Brain Stimulation on Soldiers' Cognitive and Functional Performance
A NA study, sponsored by United States Army Aeromedical Research Laboratory.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT04155333: Completed NA study, sponsored by United States Army Aeromedical Research Laboratory.
NCT04155333 is a NA study that has completed, run by United States Army Aeromedical Research Laboratory. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04155333, a NA study, has completed, sponsored by United States Army Aeromedical Research Laboratory.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Non-invasive brain stimulation has been shown to alter performance in both clinical and healthy populations on cognitive tasks. While the performance alterations have generally been shown to result in enhancement, mixed results remain in the literature. Much of the mixed results within the literature have been attributed to the use of different stimulation parameters, targeting of different brain areas, and using a variety of performance measures or assessing different constructs. However, non-invasive brain stimulation is a desirable method for enhancing Soldier performance given the ease of administration and minimal side effects as compared to other forms of performance enhancement (e.g., pharmaceuticals, caffeine). The objective of the current study is to evaluate the effects of non-invasive brain stimulation to the left dorsolateral prefrontal cortex in enhancing Soldier cognitive skills and performance on military tasks. A double blind within-subjects design will be used with healthy, rested Soldiers who will receive non-invasive brain stimulation and perform basic cognitive and operationally relevant tasks.
Primary Outcome
Patrol exertion multitask
Interventions
- DEVICE Transcranial direct current stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-12-12 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
What the finished NCT04155333 record still lists
NCT04155333 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Transcranial direct current stimulation is the first listed.
NCT04155333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04155333 about?
NCT04155333 is a clinical study titled "Effects of Non-Invasive Brain Stimulation on Soldiers' Cognitive and Functional Performance". Non-invasive brain stimulation has been shown to alter performance in both clinical and healthy populations on cognitive tasks. While the performance alterations have generally been shown to result in enhancement, mixed results remain in the literature. Much of the mixed results within the literatur...
What is the current status of trial NCT04155333?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-12-12. Estimated completion is 2021-09-30.
What interventions are being tested in trial NCT04155333?
The interventions under investigation include: Transcranial direct current stimulation (DEVICE).
Who is sponsoring clinical trial NCT04155333?
This trial is sponsored by United States Army Aeromedical Research Laboratory, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04155333's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI